Tag Archive | "FDA"

Expert says Nivolumab Poised to Change Standard of Care in SCCHN

Wednesday, August 24, 2016

0 Comments

Source: www.onclive.com Author: Laura Panjwani Nivolumab (Opdivo) is a game-changing agent for the treatment of patients with squamous cell carcinoma of the head and neck (SCCHN), according to Robert L. Ferris, MD, PhD. “Recent findings have shown us that this agent is really the new standard-of-care option for all platinum-refractory patients with head and neck […]

Continue reading...

Merck Says FDA Accepts Its SBLA For Keytruda For Treatment Of Head & Neck Cancer

Wednesday, April 13, 2016

0 Comments

Source: www.finchannel.com Author: Fin Channel News Editorial Staff   The FINANCIAL — Merck, known as MSD outside the United States and Canada, on April 13 announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of […]

Continue reading...

Nivolumab Could Change Head and Neck Cancer Treatment Paradigm

Tuesday, February 16, 2016

0 Comments

Source: www.Targetedonc.com Author: Laura Panjwani   “To have an anti–PD-1 agent be proven to improve survival in head and neck cancer in a randomized phase III trial, and the potential for a new FDA approval in the near future is a game changer.” – Robert Ferris, MD, PhD With the phase III CheckMate-141 trial being […]

Continue reading...

NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

Thursday, February 4, 2016

0 Comments

Source: www.medicine.wustl.edu Author: Washington University School of Medicine in St. Louis Staff   Approximately 79 million people in the United States are currently infected with a human papillomavirus (HPV) according to the Centers for Disease Control and Prevention (CDC), and 14 million new infections occur each year. Several types of high-risk HPV are responsible for […]

Continue reading...

FDA Clears First Tobacco Product for Marketing

Thursday, November 12, 2015

0 Comments

For the first time since it was given the power to regulate tobacco, the US Food and Drug Administration (FDA) has authorized marketing of a new product. The agency said that eight new smokeless snus products, to be sold in the United States under the “General” brand name by Stockholm-based Swedish Match AB, are now […]

Continue reading...

SA Developed Melanoma Drug Now Seen Effective in Fighting Lung Cancer

Tuesday, October 6, 2015

0 Comments

Source: www.woai.com Author: News Radio 1200 WOAI Staff   Keytruda, a cancer drug developed largely at San Antonio’s START Center, has already proven to be effective in treating advanced melanoma to the point that it is the major part of former President Jimmy Carter’s treatment.  Now, News Radio 1200 WOAI reports Keytruda has been given […]

Continue reading...

The Cost of Cancer Drugs

Monday, June 22, 2015

0 Comments

Source: www.cbsnew.com Author: Lesley Stahl   The following is a script of “The Cost of Cancer Drugs” which aired on October 5, 2014, and was rebroadcast on June 21, 2015. Lesley Stahl is the correspondent. Richard Bonin, producer. Cancer is so pervasive that it touches virtually every family in this country. More than one out […]

Continue reading...

FDA Advisory Committee hesitates to endorse message of safe smokeless tobacco

Sunday, April 12, 2015

0 Comments

Source: www.medpagetoday.com Author: Shannon Firth An FDA advisory panel were reluctant to recommend a gentler warning label for one brand of smokeless tobacco products at a committee hearing on Friday. Swedish Match North America (SMNA), the first company to be considered for a modified risk tobacco designation by the FDA, is asking to replace a […]

Continue reading...

FDA Approves Vaccine That Covers More HPV Strains

Tuesday, December 16, 2014

0 Comments

Source: webmd.com Author: E J Mundell, HealthDay Reporter   WEDNESDAY, Dec. 10, 2014 (HealthDay News) — The U.S. Food and Drug Administration last Wednesday approved a new vaccine with expanded protection against the human papillomavirus (HPV), by far the leading cause of cervical and certain other cancers. The agency said that Gardasil 9 can shield […]

Continue reading...

E-cigarette laws may be harder to regulate than originally thought

Tuesday, October 7, 2014

0 Comments

Source: apnews.com or ap.org Author: Summer Ballentine & Michael Felberbaum   JEFFERSON CITY, Mo. (AP) – In a rush to keep electronic cigarettes out of children’s hands while the federal government creeps forward with a proposed national ban for minors, experts say that many states are passing laws that could mean fewer restrictions on the […]

Continue reading...